Belvedere Trading LLC Altimmune, Inc. Transaction History

Belvedere Trading LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$2.14 - $11.62 $35,855 - $194,693	16,755 New	16,755 $188,000
Q4 2022 Feb 14, 2023	BUY	$8.74 - $16.45 $152,845 - $287,677	17,488 New	17,488 $287,000
Q4 2021 Jan 25, 2022	SELL	$8.69 - $12.48 $173,843 - $249,662	-20,005 Closed	0 $0
Q3 2021 Oct 19, 2021	BUY	$8.43 - $16.81 $168,642 - $336,284	20,005 New	20,005 $244,000

186

39.3M

913K

743K

Ticker ALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,025,300
Market Cap $404M
Description
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.